Paper33077288
Quinoa as source of type 1 ribosome inactivating proteins: A novel knowledge for a revision of its consumption.
Landi N and 6 others. Food Chem, 2021. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Quinoa as source of type 1 ribosome inactivating proteins: A novel knowledge for a revision of its consumption. Papers, record 33077288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33077288
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quinoa as source of type 1 ribosome inactivating proteins: A novel knowledge for a revision of its consumption.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chenopodium quinoa | Major topic |
| Diet | Major topic |
| Ribosome Inactivating Proteins, Type 1 | Major topic |
| Humans | |
| Seeds |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,352,938 | Purification, Amino Acid Sequence, and Structural Features of a Novel Expansin-like A from the Seeds of Canihua (Chenopodium pallidicaule Aellen). | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42352938 | PubMed |
| 40,444,089 | Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment. | Front Oncol | 2025 | https://conductscience.org/library/papers/40444089 | PubMed |
| 40,405,663 | Comparative LC-MS Proteomics of Quinoa Grains: Evaluation of Bioactivity and Health Benefits by Combining In Silico Techniques With In Vitro Assays on Colorectal Adenocarcinoma Cells. | Mol Nutr Food Res | 2025 | https://conductscience.org/library/papers/40405663 | PubMed |
| 39,200,439 | Comparative Evaluation of Chemical Composition and Nutritional Characteristics in Various Quinoa Sprout Varieties: The Superiority of 24-Hour Germination. | Foods | 2024 | https://conductscience.org/library/papers/39200439 | PubMed |
| 38,535,801 | Hortensins, Type 1 Ribosome-Inactivating Proteins from Seeds of Red Mountain Spinach: Isolation, Characterization, and Their Effect on Glioblastoma Cells. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38535801 | PubMed |
| 36,830,606 | Isolation, Characterization, and Biocompatibility of Bisporitin, a Ribotoxin-like Protein from White Button Mushroom (Agaricus bisporus). | Biomolecules | 2023 | https://conductscience.org/library/papers/36830606 | PubMed |
| 36,668,877 | A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/36668877 | PubMed |
| 36,136,552 | Characterization of Lung Injury following Abrin Pulmonary Intoxication in Mice: Comparison to Ricin Poisoning. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136552 | PubMed |
| 36,006,228 | Isolation, Characterization and Biological Action of Type-1 Ribosome-Inactivating Proteins from Tissues of Salsola soda L. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36006228 | PubMed |
| 35,737,065 | Ribotoxic Proteins, Known as Inhibitors of Protein Synthesis, from Mushrooms and Other Fungi According to Endo's Fragment Detection. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35737065 | PubMed |
| 35,267,403 | Ultrasonic Assisted Extraction of Quinoa (Chenopodium quinoa Willd.) Protein and Effect of Heat Treatment on Its In Vitro Digestion Characteristics. | Foods | 2022 | https://conductscience.org/library/papers/35267403 | PubMed |
| 34,678,977 | Cytotoxicity Effect of Quinoin, Type 1 Ribosome-Inactivating Protein from Quinoa Seeds, on Glioblastoma Cells. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34678977 | PubMed |
| 34,445,686 | The Structural Characterization and Antipathogenic Activities of Quinoin, a Type 1 Ribosome-Inactivating Protein from Quinoa Seeds. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445686 | PubMed |
| 33,808,595 | Comparison of the Chemical and Technological Characteristics of Wholemeal Flours Obtained from Amaranth (Amaranthus sp.), Quinoa (Chenopodium quinoa) and Buckwheat (Fagopyrum sp.) Seeds. | Foods | 2021 | https://conductscience.org/library/papers/33808595 | PubMed |
| 33,802,023 | Valle Agricola Chickpeas: Nutritional Profile and Metabolomics Traits of a Typical Landrace Legume from Southern Italy. | Foods | 2021 | https://conductscience.org/library/papers/33802023 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RIPK1 | 8,737 | PubTator's text mining | https://conductscience.org/library/genes/8737 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33077288
GET https://conductscience.org/api/papers/v1/33077288/authors